-
121
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries
Published 2025-01-01“…Hazard ratios (HR) for resolution comparing different joint locations were estimated using interval-censored mixed-effects Cox proportional hazards models, including a random effect for country and patient, adjusted for age and sex. …”
Get full text
Article -
122
Dissemination of the Russian emigrant literature and the literature of the Book Program in East Europe in 1950-1990
Published 2024-08-01“…A great number of posted books managed to bypass Soviet and Eastern European censors and customs, and some of them reached Lithuania. …”
Get full text
Article -
123
Comparative analysis of ambient, in-home, and personal exposures reveals associations between breathing zone pollutant levels and asthma exacerbations in high-risk children
Published 2025-01-01“…Personal exposures were tested for association with lung function and compared between participants with and without well-controlled asthma and signs of exacerbation in the prior 60 days using censored regression with robust standard errors. Results 81 children completed 219 monitoring sessions. …”
Get full text
Article -
124
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the Che...
Published 2024-02-01“…Exploratory analyses included efficacy by tumor PD-L1 expression and histology and in patients who discontinued nivolumab plus ipilimumab with chemotherapy due to treatment-related adverse events (TRAEs), and a treatment-switching adjustment analysis using inverse probability of censoring weighting.Results With a 47.9-month minimum follow-up for OS, nivolumab plus ipilimumab with chemotherapy continued to prolong OS over chemotherapy in all randomized patients (HR 0.74, 95% CI 0.63 to 0.87; 4-year OS rate: 21% versus 16%), regardless of tumor PD-L1 expression (HR (95% CI): PD-L1<1%, 0.66 (0.50 to 0.86) and ≥1%, 0.74 (0.60 to 0.92)) or histology (squamous, 0.64 (0.48 to 0.84) and non-squamous, 0.80 (0.66 to 0.97)). …”
Get full text
Article -
125
Julius Kruopis – the pioneer of applied statistics in Lithuania
Published 2023-12-01“…Selective control'', ``Nonparametric tests for complete data'', ``Nonparametric tests for censored data''. While working at the university, J. …”
Get full text
Article